Methods and pharmaceutical compositions for treating human immunodeficiency virus type 1 (HIV-1) infections
US9938528B2 · kind B2 · utility
0Cited by
0References
19Claims
0Family size
Assignees
- Institut National de la Sante et de la Recherche Medicale (INSERM)
- UNIVERSITÉ PARIS-SUD
- INSTITUT GUSTAVE ROUSSY
- UNIVERSITE DE PARIS DESCARTES
- Université Pierre et Marie Curie
- INSTITUT PASTEUR
- INSTITUTO NAZIONALE PER LE MALATTIE INFETTIE IRCCS LAZZARO SPALLANZANI
- ASSISTANCE PUBLIQUE—HÔPITAUX DE PARIS (APHP)
Inventors
Key dates
| Filing date | Dec 10, 2015 |
| Grant date | Apr 10, 2018 |
| Priority date | — |
| Expiry date | Dec 10, 2035 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2320/31
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides methods and pharmaceutical compositions for treating human immunodeficiency virus type 1 (HIV-1) infections. In particular, the present invention relates to a method for treating HIV-1 infection in a subject in need thereof comprising administering the subject with a therapeutically effective amount of an inhibitor of SGT1 activity or expression.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.